Are female sex hormones teratogenic?

American Journal of Obstetrics and Gynecology

Volumn 141, Issue 5, 1981, Pages 567-580

  Wilson, J G ^a   Brent, R L ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN DERIVATIVE; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE DERIVATIVE; SEX HORMONE;

ADVERSE DRUG REACTION; BONE; CONGENITAL DISORDER; CONGENITAL MALFORMATION; EMBRYO; EMBRYOLOGY; ENDOCRINE SYSTEM; EPIDEMIOLOGY; FETUS; GREAT BLOOD VESSEL; GREAT VESSELS TRANSPOSITION; LIMB MALFORMATION; PREGNANCY; PRENATAL DRUG EXPOSURE; TERATOGENESIS; TERATOGENICITY;

EID: 0019855213     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9378(15)33279-8     Document Type: Review

References (93)

1. F.R. Lillie The theory of the freemartin Science 43 1916 611
2. F.R. Lillie The freemartin: A study of the action of sex hormones in the foetal life of cattle J. Exp. Zool 23 1917 371
3. K. Keller J. Tandler Uber das Verhalten der Echaute bei der Zwillingstrachtigkeit des Rindes. Untersuchungen uber die Entslehungsursache der geschlechtichen Unterentwicklung von Weiblichen Zwillingskalbern, welche neben einen Mannlechen Kalbe zur Entwicklung Gelangen, Wien Tierarztl. Wochenschr 3 1916 513
4. V. Dantchakoff Sur la faculte des tissue induit par l’hormone male, d’edifier de nouvelles structures chez l’embryon de cobaye femelle, C.R Soc. Biol 124 1937 516
5. A. Raynaud Masculinization des embryons femelles de souris par injection de dehydroandrosterone a la mere en gestation, C.R Soc. Biol 129 1938 289
6. A. Raynaud Etude de l’appareil genital (gonades, cannaux de Wolff et de Muller) des souris males intersexuees obtenues par injection de dipropionate d’oestradiol a la mere en gestation, C.R Soc. Biol 130 1939 1012
7. C.D. Turner The modification of sexual differentiation in genetic female mice by the prenatal administration of testosterone propionate J. Morphol 65 1939 353
8. R.R. Greene M.W. Burrill A.C. Ivy Experimental intersexuality: The effect of antenatal androgens on sexual development of female rats Am. J. Anat 65 1939 415
9. R.R. Greene M.W. Burrill A.C. Ivy Experimental intersexuality: The paradoxical effects of estrogens on the sexual development of the female rat, Anat Rec 74 1939 429
10. R.R. Greene M.W. Burrill A.C. Ivy Experimental intersexuality: The effects of estrogens on the antenatal sexual development of the rat Am. J. Anat 67 1940 305
11. C. Revesz C.I. Chappel R. Gaudry Masculinization of female fetuses in the rat by progestational compounds Endocrinology 66 1960 140
12. G.K. Suchowsky K. Junkmann A study of the virilizing effect of the progestogens on the female rat fetus Endocrinology 68 1961 341
13. J. Zander H.A. Muller Uber die Methylandrostendiol-behandlung wahrend einer Schwangerschaft; Geburtschilfe Frauenheilkd 13 1953 216
14. M.M. Grumbach J.R. Ducharme The effects of androgens on fetal sexual development: Androgen-induced female pseudohermaphroidism, Fertil Steril 11 1960 157
15. R.L. Cahen Experimental and c1inical chemoteratogenesis S. Garottini P.A. Shore Advances in Pharmacology 1966 Academic Press, Inc. New York 263 284
16. M.L. Voorhess Masculinization of the female fetus as sociated with norethindrone mestranol therapy during pregnancy J. Pedialr 71 1967 128
17. L. Wilkins H.W. Jones G.H. Holman R.S. Stempfel Masculinization of female fetus associated with administration of oral and intramuscular progestins during gestation: Non-adrenal pseudohermaphroditism J. Clin. Endocrinol. Metab 18 1958 559
18. L. Wilkins Masculinization of female fetus due to use of orally given. progestins JAMA 172 1960 1028
19. A.M. Bongiovanni A.J. McFadden Steroids during pregnancy and possible fetal consequences, Fertil Steril 11 1960 181
20. H. Uhlig Fehlbildungen nach Pollikelhormonen beim Menschen Geburtshilfe Frauenheilkd 19 1959 346
21. L. Assemany Gardner S.R., and Neu, R.L.: 46XY female: Antiandrogenic effect of oral contraceptive? Lancet 2 1970 667
22. Z. Papp S. Gardo Effect of exogenous hormones on the fetus Lancet 1 1971 753
23. B. Gal Kirman J. Stern Hormonal pregnancy tests and congenital malformations Nature %16 1967 83
24. M. Laurence M. Miller M. Vowles K. Evans C. Carter Hormonal pregnancy tests and neural tube malformations Nature 258 1971 495
25. K.M. Laurence Reply to Gal, Nature 240 1972 242
26. L.E. Sever Hormonal pregnancy tests and spina bifida Nature 242 1973 410
27. E.P. Levy A. Cohen F.C. Fraser Hormone treatment during pregnancy and congenital heart disease Lancet 1 1973 611
28. J.J. Nora A.H. Nora Preliminary evidence for a possible association between oral contraceptives and birth defects Teratology 7 1973 A24
29. J.J. Mulvihill C.G. Mulvihill C. Neill Prenatal sex-hormone exposure and cardiac defects in man Teratology 9:A-30 1974
30. H. Nishimura C. Uwabe R. Semba Examination of teratogenicity of progestogens and/or estrogens byobservation of the induced abortuses Teratology 10 1974 93
31. M. Yasuda J.R. Miller Prenatal exposure to oral contraceptives and transposition of the great vessels in man Teratology 12 1975 239
32. D.T. janerich J.M. Piper D.M. Glebatis Oral contraceptives and congenital limb-reduction defects N. Eng!. J. Med 291 1974 697
33. J.G. Wilson Environment and Birth Defects 1973 Academic Press, Inc New York
34. W. Lenz Malformations caused by drugs in pregnancy Am. J. Dis. Child 112 1966 99
35. P. Jaffe M.M. Liberman McFadyen, and Valman, H.B.: Incidence of congenital limb reduction deformities Lancet 1 1975 526
36. B. Hellstrom J. Lindsten K. Nilsson Prenatal sex-hormone exposure and congenital limb reduction anomalies Lancet 2 1976 372
37. Congenital Malformations Surveillance Report. Issues of june and November, Center for Disease Control, Adanta, 1978.
38. O.P. Heinonen D. Slone S. Shapiro Birth Defects and Drugs in Pregnancy 1977 Publishing Science Group, Inc Littleton, Mass.
39. G.P. Oakley M.J. Safra Exogenous female hormones and birth defects Teratology 20A 1977 15
40. J. Martinie-Dubousquet Embryopathy entailed by administration of sex hormones to the mother Rev. Patho!. Gen. Compo 53 1953 1065
41. M. Ahlgren B. Kallen G. Rannevik Outcome of pregnancy after clomiphene therapy, Acta Obstet Gynecol. Scand 55 1976 371 375
42. S. Papp Gardo B. Dolhay G.Y. Ruzicska Indirect effect of sex hormones on the fetus. ] PediaL 88 1976 524
43. D. Janerich J.M. Piper D.M. Glebatis Oral contraceptives and birth defects Am. J Epidemiol 112 1980 73
44. E. Matsunaga K. Shiota Threatened abortion, hormone therapy and malformed embryos Teratology 20 1979 469
45. O.P. Heinonen D. Slone R.R. Monson E.B. Hook S. Shapiro Cardiovascular defects and antenatal exposure to female sex hormones N. Engl. J. Med 296 1977 67
46. J.J. Nora A.H. Nora J. Blu J. Ingram A. Fountain M. Peterson R.H. Lortscher W.J. Kimherling Exogenous progestogen and estrogen implicated in birth defects JAMA %40 1978 837
47. D.T. Janerich J.M. Dugan S. Standfust L. Strite Congenital heart disease and prenatal exposure to exogenous sex hormones, Br 1977 Med J. I 1058
48. C. Ferencz G.M. Matanoski P.D. Wilson J. Rubin C. Neill R. Gutberlet Maternal hormone therapy and congenital heart disease Teratology 1979
49. S. Harlap R. Prywes A.M. Davies Birth defects and oestrogens and progesterones in pregnancy Lancet 1 1975 682 683
50. S. Dillon Progestogen therapy in early pregnancy and associated congenital defects Practitioner 205 1970 80
51. J. Robertson-Rintoul Oral contraception: Potential hazards of hormone therapy during pregnancy Lancet 2 1974 515
52. G. Greenberg W.H.W. Inman J.A.C. Weatherall A.M. Adelstein Hormonal pregnancy tests and congenital malformations Br. Med. J. % 1975 191
53. G. Greenberg W.H.W. Inman J.A.C. Weatherall A.M. Adelstein J.C. Haskey Maternal drug histories and congenital abnormalities Br. Med. J 2 1977 853
54. Dillon, S.: Congenital malformations and hormones in pregnancy, Br. Med. J %:1446,1976.
55. Nora, J. and Nora, A. H.: Birth defects and oral contraceptives, Lancet 1:941, 1973.
56. Nora, A. H., and Nora, J J: A syndrome of multiple congenital anomalies associated with teratogenic exposure, Arch. Environ. Health 30:17,1975.
57. Kaufman, R. L.: Birth defects and oral contraceptives, Lancet 1:1396, 1973.
58. Bald, S., Say, B., Pirnar, T., and Hicsonmez: Birth defects and oral contraceptives, Lancet 2:1098, 1973.
59. Serra, G., Fossaei, F. L., Clinque, N. A., and Bruschettini, P. A recently classified multiple malformative syndrome, Minerva Pediatr. 27:1142,1975.
60. Buffoni, L., Tarateta, and Pecorari, D.: The V.A.E.T.E.R.L. syndrome: A new association of multiple congenital deformities as a possible outcome of hormone administration during pregnancy. Minerva Ginecol. %8:382, 1976.
61. David, T. J., and O’Callaghan. S. E.: Birth defects and oral hormone preparations, Lancet 1:1236, 1974.
62. Brent, R. L.: Litigation-produced pain, disease and suffering: An experience with congenital malformation lawsuits, Teratology I, 1977.
63. Spira, N., Goujard, J., Huel, G., and C.: Etude teratogene des hormones sexueJles .. Premiers resultats d’une enquete epidemiologique portant sur 20,000 femmes, Rev. Fr. 1972.
64. Herbst A. L., Scully. R. E., Robboy, S. J., and Welch, W. R.: Complicationsofpnmataldrerapy with diethylstilbestrol, Pediatrics 115), 1978.
65. Mack, T. M.: Postmenopausal carcinoma as a result of estrogen treatment: Survey of evidence, Pediatrics 62: 1978.
66. Ryder, B., and Westoff, C. F.: of oral contraceptives in the Unites States, 1965, Science 15!hll99, 1966.
67. Segal, S.].: Contraceptives and the young: Present status and future prospects, Pediatrics 62:1211,1978.
68. Rosenfield, A.: Oral and intrauterine contraception: A 1978 risk assessment, AM.}. OBSTET. GYNECOL. 132:92, 1978.
69. Vessey, M. P.: Contraceptive methods: and benefits, Br. Merl.}. 2:721, 1978.
70. Seigel, D., and Corfman, P.: Epidemiological problems associated with studies of the safety of oral contraceptives, JAMA2OSt950, 1968.
71. Clark,}. H., Hardin,}. W., and McCormack, S. A.: Estrogen receptor binding and growth of the reproductive tract, Pediatrics 62:1121,1978.
72. Gorski, J., and Gannon, F.: Current models of steroid hormone action: A critique, Ann. Rev. Physiol. 38:425, 1976.
73. Jensen, E. V., and DeSombre, E. R.: Mechanism of action of the female sex hormones, Ann. Rev. Biochem. 41:203, 1972.
74. O’Malley, B. W., and Means, A. R.: Female steroid hormones and target cell nuclei, Science 183:610, 1974.
75. Janerich, D. T.: Supportive hormone therapy and birth defects, Teratology 20:483, 1979.
76. Oakley, G.: Threatened abortion, hormone therapy and malfonned embryos, Teratology 20:481, 1979.
77. Matsunaga, E., and Shiota, K.: Response to Dr. D. T. Janerich’s Letter to the Editor, Teratology 20:485, 1979.
78. Banks, A. Rutherford, R. and Coburn, W. A.: Pregnancy and progeny after use of progestin-like sub-; stances for contaception, Obstet. Gynecol. 26:760, 1965.
79. Bracken, M. B., Holford, T. R., White, C., and Kelsey, J. Role of oral contraception in congenital malformations of offspring, Int. j. Epidemiol. 7:309, 1978.
80. Janerich, D. T., Flink, E. M., and Keogh, M. D.: Down’s syndrome and oral contraceptive usage, Br. j. Obstet. Gynaecol. 83:617, 1976.
81. Peterson, W. F.: Pregnancy following oral contraceptive therapy, Obstet. Gynecol. 34:363, 1969.
82. Goujard, j., and Rumeau-Rouquette, C.: First-trimester exposure to progestagen/oestrogen and congenital malformations, Lancet 1:482, 1977.
83. Reinisch, Prenatal exposure of human foetuses synthetic progestin and oestrogen affects personaltiy, ature 266:561, 1977.
84. Robinson, S. C.: Pregnancy outcome following oral contraceptives, OBSTET. GVNECOL. 109:354, 1971.
85. Rutenskold, M.: Pregnancies during oral contraceptive treatment. Swedish experiences, Acta Obstet. Gyneco!. Scand. 50:203, 1971.
86. Rothman, K. andLouik, C.: Oral contraceptives and birth defects, Engl. j. Med. 299:522. 1978.
87. Tuchmann-Duplessis, H.: Teratogenic screening methods and their application to contraceptive· products, Briggs, M. H., and Diczfalusy, E., editors: Pharmacological Models in Contraceptive Development,Stockholm, 1973, WHO Research and Training Center on Human Reproduction, pp. 203-219.
88. Rice-Wray. E., Cervantes. A., Gutierrez, j., and Marquez- Monter, H.: Pregnancy and progeny after hormonal contraceptives-genetic studies, }. Reprod. Med. 6:101,1971.
89. Smithells, R. W.: The problem of teratogenicity,Practitioner 194:104, 1965.
90. Wild,]., Schorah, C.j., and SmitheHs, R. W.: Vitamin A, pregnancy and oral contraceptives, Br. Med. j. 1:57-59, 1974.
91. Poland, B. J., and Ash, K. A.: The influence of recent use of an oral contraceptive on early intrauterine development, AM. j. OSSTET. GVNECOL. U6:1138, 1973.
92. Brent, R. Methods of evaluating alleged human teratogens, Teratology 17:183, 1978.